Tai-Lung Cha

Papers

Total Citations

H-Index

About

Tai-Lung Cha is a prominent researcher in urological oncology, with a focus on improving prostate cancer prognosis through computational modeling. His key research areas include artificial intelligence applications in cancer staging, biomarker discovery, and precision medicine for prostate cancer. Cha’s major contribution is the development of an artificial neural network (ANN) model to predict pathological stage in clinically localized prostate cancer, specifically tailored for a Taiwanese population. This work, published in 2014 and cited 26 times, demonstrated that ANN outperforms traditional logistic regression by integrating variables such as age, prostate-specific antigen (PSA), and body mass index, offering more accurate preoperative staging. By advancing machine learning in clinical decision-making, Cha’s research enhances risk stratification and treatment planning, reducing unnecessary radical prostatectomies. His impact lies in bridging computational methods with urological practice, providing a reproducible framework for population-specific cancer prediction. Notable achievements include pioneering ANN-based staging in Asian cohorts, addressing disparities in Western-centric models. For students and researchers, Cha’s work exemplifies how interdisciplinary approaches—combining oncology, statistics, and AI—can transform cancer care, making his profile a compelling case study in translational bioinformatics.